Full-Spectrum Blog Contact Info CRISPR/Cas9 Programs & Pipeline Patients & Families Healthcare Professionals Healthcare Professionals Intellia is committed to working closely with healthcare professionals to improve the standard of care for patients by harnessing the power of CRISPR/Cas9-based genome editing . We are developing potential single-adminstration therapies for people living with severe and life-threatening conditions, including cancer and genetic disorders. How We Are Developing CRISPR/Cas9-Based Treatments At Intellia, we utilize a modular genome editing platform to create a diverse pipeline, including programs that apply genome editing in vivo , where the CRISPR/Cas9 components are delivered as the therapy, and ex vivo , where we use our CRISPR/Cas9 technology as a tool to create engineered, cell-based therapies . LEARN ABOUT OUR FULL-SPECTRUM APPROACH CHECK OUT OUR PROGRAMS Access to Our Investigational Medicines Intellia is committed to solving the complex challenges of making CRISPR/Cas9-based medicines a reality for patients suffering with severe and life-threatening genetic diseases. Under certain circumstances, a person suffering a serious or life-threatening disease may ask to use an experimental treatment outside a clinical trial , before its safety and efficacy have been fully evaluated, and before the regulatory authorities have approved it. Intellia appreciates the intent of expanded access programs but, at this time, we can best advance the development of these potential promising products by enrolling patients in clinical trials. Click here to read our full expanded access policy. If you have questions regarding information on our programs, check out our pipeline or contact medicalaffairs@intelliatx.com. Publications and Resources VIEW INTELLIA’S SCIENTIFIC PRESENTATIONS AND PUBLICATIONS VIEW RESOURCES TO LEARN MORE ABOUT GENOME EDITING Info Overview Leadership Partners Healthcare Professionals Overview CRISPR/Cas9 What’s CRISPR/Cas9? How CRISPR/Cas9 Works Types of Edits Glossary Investors & Media Overview Press Releases Corporate Deck Events & Presentations Press Kit Corporate Governance Financial Info Stock Info Analyst Coverage Investor Resources Programs & Pipeline Intellia’s Full-Spectrum Approach Pipeline In Vivo Therapies Ex Vivo Therapies Careers Life @ Intellia Join Us Patients & Families Our Commitment Clinical Trials Community Perspectives & Resources Expanded Access Policy © Intellia Therapeutics, Inc. 2021 Cookie Policy Terms of Use Privacy Policy Intellia Therapeutics and the Intellia Therapeutics logo are registered trademarks with the U.S. Patent & Trademark Office.